Cargando…
Nucleocapsid Antigenemia Is a Marker of Acute SARS-CoV-2 Infection( )
Detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is essential for diagnosis, treatment, and infection control. Polymerase chain reaction (PCR) fails to distinguish acute from resolved infections, as RNA is frequently detected after infectiousness. We hypothesized that...
Autores principales: | Verkerke, Hans P, Damhorst, Gregory L, Graciaa, Daniel S, McLendon, Kaleb, O’Sick, William, Robichaux, Chad, Cheedarla, Narayanaiah, Potlapalli, Sindhu, Wu, Shang-Chuen, Harrington, Kristin R V, Webster, Andrew, Kraft, Colleen, Rostad, Christina A, Waggoner, Jesse J, Gandhi, Neel R, Guarner, Jeannette, Auld, Sara C, Neish, Andrew, Roback, John D, Lam, Wilbur A, Shah, N Sarita, Stowell, Sean R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384592/ https://www.ncbi.nlm.nih.gov/pubmed/35877413 http://dx.doi.org/10.1093/infdis/jiac225 |
Ejemplares similares
-
Nucleocapsid Antigenemia in Patients Receiving Anti-CD20 Therapy With Protracted COVID-19
por: Wilber, Eli, et al.
Publicado: (2022) -
Rapid, high throughput, automated detection of SARS-CoV-2 neutralizing antibodies against native-like vaccine and delta variant spike trimers
por: Cheedarla, Narayanaiah, et al.
Publicado: (2022) -
Investigation of Blood Plasma Viral Nucleocapsid Antigen as a Marker of Active Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Infection
por: Damhorst, Gregory L, et al.
Publicado: (2023) -
Rapid, high throughput, automated detection of SARS-CoV-2 neutralizing antibodies against Wuhan-WT, delta and omicron BA1, BA2 spike trimers
por: Cheedarla, Narayanaiah, et al.
Publicado: (2023) -
Estimating severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence from residual clinical blood samples, January–March 2021
por: Graciaa, Daniel S., et al.
Publicado: (2022)